Li Yang

No. 1 Jianshe East Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and immunosuppressive cell induction in cancer mouse models.

Macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and immunosuppressive cell induction in cancer mouse models.

Journal: Nature communications

Published: September 05, 2025

Single-cell sequencing and network pharmacology coupled with molecular docking and experimental validation reveal the effects of YPFS on macrophages in stage I non-small cell lung cancer.

Single-cell sequencing and network pharmacology coupled with molecular docking and experimental validation reveal the effects of YPFS on macrophages in stage I non-small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: August 28, 2025

β-receptor blocker enhances anti-tumor immunity via inhibiting lactate-induced norepinephrine metabolism of macrophages during malignant pleural effusion.

β-receptor blocker enhances anti-tumor immunity via inhibiting lactate-induced norepinephrine metabolism of macrophages during malignant pleural effusion.

Journal: Frontiers in immunology

Published: September 17, 2024

Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer.

Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: September 15, 2024

A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer.

A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer.

Journal: Cell

Published: July 17, 2024

A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues.

A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues.

Journal: Scientific data

Published: April 08, 2024

A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis.

A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis.

Journal: Cancer immunology, immunotherapy : CII

Published: January 26, 2024

Sulforaphane activates CD8+ T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'.

Sulforaphane activates CD8+ T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'.

Journal: Journal for immunotherapy of cancer

Published: December 04, 2023

Dynamic surveillance of lymphocyte subsets in patients with non-small cell lung cancer during chemotherapy or combination immunotherapy for early prediction of efficacy.

Dynamic surveillance of lymphocyte subsets in patients with non-small cell lung cancer during chemotherapy or combination immunotherapy for early prediction of efficacy.

Journal: Frontiers in immunology

Published: October 10, 2023

Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.

Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.

Journal: Cancer immunology, immunotherapy : CII

Published: August 04, 2021

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway.

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway.

Journal: BMC medicine

Published: July 16, 2021

Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling.

Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling.

Journal: Cancer immunology, immunotherapy : CII

Published: September 14, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026